West Coast Research — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

West Coast Research LLC is a private, single-site clinical research site that has been operational since 2007. It functions as a service provider, enrolling patients into clinical trials sponsored by pharmaceutical companies and CROs, generating revenue through contracted research services. The company's model is site-focused rather than developing its own technology, positioning it within the broader clinical trial execution ecosystem. Its current activities appear centered on later-phase (likely Phase 3/4) patient recruitment for chronic conditions.

GoutHypertensionCardiovascular

Technology Platform

Operational clinical trial site infrastructure and patient recruitment database, not a proprietary therapeutic or diagnostic technology.

Opportunities

Leveraging its Bay Area location to access a large patient pool for high-demand clinical trials in chronic diseases.

Building a reputation for quality and reliability to secure repeat business from major pharmaceutical sponsors and CROs.

Risk Factors

Revenue is entirely dependent on winning competitive contracts for specific trials, leading to volatility.

Heavy reliance on successful and timely patient recruitment for each study; enrollment delays directly impact finances and reputation.

Regulatory compliance risk as a single-site operation with limited redundancy.

Competitive Landscape

Competes with other independent clinical trial sites, site networks (e.g., ICON plc site alliances, Parexel's affiliated sites), and hospital-based research units in the Northern California region. Differentiation is based on patient recruitment speed, data quality, and principal investigator expertise.

More companies in Digital Health & Biotech SaaS →More companies in United States →